April 6, 2023
PeptiDream said on April 5 that it has achieved a development milestone for its macrocyclic peptide candidates in its drug discovery alliance with German-based Bayer. The macrocyclic peptide candidates discovered through the joint R&D deal, concluded in November 2017 and...read more